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Editors: Anton N. Sidawy and Bruce A. PerlerUse of angiotensin converting enzyme inhibitors is associated with
increased growth rate of abdominal aortic aneurysms
MichaelJ.Sweeting, SimonG.Thompson,LouiseC.Brown,RogerM.Greenhalgh,
Janet T. Powell
Objectives: To evaluate whether either angiotensin converting enzyme
(ACE) inhibitors or other classes of antihypertensive drug attenuate or
increase growth rates of small infrarenal abdominal aortic aneurysms.
Methods: Prospective cohort study of 1701 patients enrolled in the UK Small
Aneurysm Trial or associated study at 93 hospitals between 1991 and 1995
and who had at least two ultrasound measurements of aneurysm diameter
and baseline drug prescription data recorded. Abdominal aortic aneurysm
diameter was measured in the anterior-posterior plane using ultrasound.
The mean growth rate was estimated through a mixed-effects linear growth
model.
Results: Mean aneurysm growth rate in 169 patients taking ACE inhibitors
at baseline was 3.33 mm/y vs 2.77 mm/y in the remaining 1532 patients,
P = .009. The significance of this finding did not alter after adjustment for
known confounders. The prescription of any antihypertensive agent and
other specific classes of antihypertensive drugs were not found to be associ-
ated with aneurysm growth rate.
Conclusion: These results show that patients taking ACE inhibitors have fas-
ter aneurysm growth and are in conflict with the observation from a large
Canadian data-base that aneurysm patients taking ACE inhibitors are less
likely to present with aneurysm rupture. There is an urgent need for
a randomized trial to assess whether ACE inhibitors are beneficial or harmful
to patients with aneurysms below the threshold size for surgical intervention.Endovascular aneurysm repair is superior to open surgery for ruptured
abdominal aortic aneurysms in EVAR-suitable patients
Jan A. Ten Bosch, Joep A.W. Teijink, Edith M. Willigendael, Martin H. Prins
Objective: Efficacy results of endovascular repair (rEVAR) for ruptured
abdominal aortic aneurysm (rAAA) compared with open surgery are based
on several observational studies containing selection bias. The present study
compared rEVAR with open surgery in EVAR-suitable patients with an rAAA
who all underwent the same preoperative imaging protocol.
Methods: Our policy is to perform a computed tomography angiography on
all patients with a suspected rAAA. rEVAR was performed when the rEVAR-
vascular surgeon was on call and the patient was suitable for EVAR. After-
wards, two experienced independent blinded experts assessed all computed
tomography angiography (CTA) scans on EVAR-suitability. Only EVAR-suitable
patients were included in the main analyses. Outcome parameters included
mortality (intraoperative, 30-day, and 6-month), complications, reinterven-
tions, and length of hospital stay.
Results: From April 2002 until March 2008, 132 consecutive patients with
suspected rAAAs were presented. Preoperative CTA confirmed rAAA in 104* Full articles available online at www.jvascsurg.org
1078e5884/$36.00
doi:10.1016/S1078-5884(10)00362-Xpatients, of whom 25 underwent rEVAR, and 79 underwent open surgery.
In retrospect, the 25 rEVAR patients and 33 patients in the open group were
judged EVAR-suitable by the experts. At baseline, there was an equal distri-
bution of physiologic and anatomic characteristics as well as comorbidity. In
EVAR-suitable patients, the intraoperative, 30-day, and 6-month mortality
was 4.0% (1 of 25), 20.0% (5 of 25), and 28.0% (7 of 25) after rEVAR compared
with 6.1% (2 of 33; P >.99), 45.5% (15 of 33; P = .04), and 54.5% (18 of 33;
P = .04) after open surgery, respectively. Median length of hospital stay
was 9.5 days (interquartile range, 5.0-20.5) after rEVAR and 17.0 days (inter-
quartile range, 9.5-28.0) after open surgery (P = .03).
Conclusions: In EVAR-suitable patients, an absolute perioperative mortality
reduction of 25.5% of rEVAR over open surgery was found, which was still
present at 6 months of follow-up. These data suggest that rEVAR is a superior
treatment option for EVAR-suitable patients with an rAAA compared with an
open surgery.An analysis of drug modulation of abdominal aortic aneurysm growth
through 25 years of surveillance
Andrew Thompson, Jackie A. Cooper, Michael Fabricius, Steve E. Humphries,
Hilary A. Ashton, Hany Hafez
Background: A modest (41%) reduction in abdominal aortic aneurysm (AAA)
growth rate is likely to delay AAA-related events (surgery or rupture) by 5
years, making the notion of AAA medical treatment very appealing. Random-
ized controlled trials of commonly used existing medications are expensive
and ethically questionable. This study reviewed the independent associa-
tions of commonly used medications and AAA growth during a 25-year period
of AAA surveillance.
Methods: The study included all patients monitored through an AAA
screening and surveillance program. Records of AAA size, risk factors,
outcomes, death, and medications were entered into a continually updated
database. AAA growth rates were calculated using a flexible hierarchical
model. A multivariate model was used to test for associations independent
of confounders.
Results: The study comprised 1269 patients (94.1% men) who had a mean
age of 67 years. The median starting diameter was 35 mm, the end diameter
was 44 mm, and follow-up was 3.4 years. Drugs used in the treatment of dia-
betes were associated with a 56% reduction in AAA growth rate (P = .01)
independent of confounding factors, including other therapeutic agents
(P = .003). Angiotensin-receptor blockers and potassium-sparing diuretics
were also associated with slower AAA growth rates, although these effects
were not independent of all confounders.
Conclusion: Diabetes or its medications, or both, have a negative effect on
AAA growth. Because of polypharmacy, demonstrating the independent
effects of individual drugs affecting the renin-angiotensin system was not
possible. In light of this analysis, however, strong associations between
angiotensin-receptor blockers and aldosterone-receptor blockers and slowed
AAA progression are credible.
142 AbstractsAn unfavorable dietary pattern is associated with symptomatic ischemic
stroke and carotid atherosclerosis
Guillaume Mahe, Thomas Ronziere, Bruno Laviolle, Ve´ronique Golfier,
Thomas Cochery, Jean-Michel De Bray, Franc¸ois Paillard
Objective: Ischemic strokes represent more than 80% of total strokes in
Western countries. The influence of dietary factors on ischemic stroke risk
is debated mainly because available data are limited. Our objective was
to compare the dietary pattern of symptomatic ischemic stroke patients
under 65 years old with control subjects using a validated 14-item food
frequency questionnaire (FFQ). We also compared symptomatic ischemic
stroke patients with carotid atherosclerosis with those without according
to the presence or the absence of carotid plaque defined by duplex scanning.
Methods: This was a case-control multi-center study that took place in one
University hospital and two general hospitals in France. One hundred
twenty-four symptomatic ischemic stroke patients (confirmation by a neurol-
ogist and imaging; 66% smokers) and 50 controls (34% smokers) without any
known cardiovascular disease or previous nutritional advice were included.
The main outcome measure(s) were intake scores for saturated (SFA), mono-
unsaturated (MUFA), U-3 polyunsaturated (U-3 PUFA), and U-6 polyunsatu-
rated fatty acids (U-6PUFA). Fruit and vegetables and an overall
cardiovascular dietary score were evaluated with the FFQ. The overall
cardiovascular score is calculated as (MUFA + U-3 PUFA + fruits and vegeta-
bles) e (SFA) scores.
Results: Compared with controls, ischemic stroke patients had a higher SFA
score (6.6  3.0 vs 4.9  2.7; P < .001), lower scores of MUFA (0.8  0.9 vs
1.5  1.2; P < .001), U-3 PUFA (1.7  1.6 vs 2.2  1.5; P = .013), U-6PUFA
(2.6  2.5 vs 3.9  2.7; P = .002), fruit and vegetables (2.9  1.7 vs 3.8 
1.6; P = .005), and a lower overall dietary score (1.2  5.0 vs 2.5  4.4;
P < .001). These results remained statistically significant after adjustment
for age, gender, and smoking status. Ischemic stroke patients with carotid
atherosclerosis (n = 54) had a worse overall cardiovascular dietary score than
those without (n = 68): 2.2  4.4 vs 0.2  5.2; P = .024.
Conclusion: Compared with controls, ischemic stroke patients, especially
those with carotid atherosclerosis, have an unfavorable dietary pattern (high
SFA, low fruit and vegetables, and U-3 PUFA consumptions) that may have
been a facilitating condition of the ischemic stroke. Dietary recommenda-
tions of a healthy diet should be useful in ischemic stroke prevention, espe-
cially in patients with cardiovascular risk factors.Biomarkers in peripheral arterial disease patients and near- and longer-
term mortality
Michael H. Criqui, Lindsey A. Ho, Julie O. Denenberg, Paul M. Ridker,
Christina L. Wassel, Mary M. McDermott
Background: Whether novel biomarkers improve risk prediction of mortality
beyond standard cardiovascular disease (CVD) risk markers in peripheral
arterial disease (PAD) patients, and whether any such prediction differs with
length of follow-up, remains controversial. Our objective was to determine
in patients with PAD whether novel biomarkers improve prediction of CVD
mortality and total mortality.
Methods: A cohort of 397 patients who were referred to a vascular lab had
PAD diagnosed by noninvasive testing. Fifty-eight percent also had coronary
or cerebrovascular disease at baseline. Predictors of total, CVD, and non-
CVD mortality were assessed with Cox proportional hazards models, and
the incremental value of predictors was evaluated with both the C-statistic
and the integrated discrimination improvement (IDI) index.
Results: Total mortality was 11% at 2-year follow-up and 65% at an average
of 6.6-year of follow-up (maximum, 11.4 years). At 2 years, hs-CRP was
a strong and significant predictor of mortality, with a hazard ratio (HR) of
1.56 per standard deviation (P = .006). However, at full follow up, standard
CVD risk markers were significant (age, gender, ankle-brachial index, other
CVD, and hypertension), but hs-CRP no longer showed a significant relation-
ship (HR 1.12; P = .11). None of the other biomarkers studied showed a signif-
icant independent association with mortality. Hs-CRP improved the
C-statistic and the IDI beyond standard risk markers at 2 years, but not at full
follow-up.
Conclusions: hs-CRP was a strong predictor of short-term mortality in this
cohort of PAD patients, while standard risk markers were better at predict-
ing longer-term mortality.Outcomes of selective tibial artery repair following combat-related
extremity injury
Capt. Gabriel E. Burkhardt, Lt. Col. Mitchell Cox, Lt. Col.W. Darrin Clouse,
Chantel Porras, Capt. Shaun M. Gifford, Ken Williams, Capt. Brandon W.
Propper, Lt. Col. Todd E. Rasmussen
Objective: Selective tibial revascularization refers to the practice of vessel
repair vs ligation or observation based on factors observed at the time of
injury. Although commonly employed, the effectiveness of this strategy
and its impact on sustained limb salvage is unknown. The objective of this
study is to define the factors most relevant in selective tibial artery revascu-
larization and to characterize limb salvage following tibial-level vascular
injury.
Methods: The cohort of active-duty military patients undergoing infrapopli-
teal artery repair comprises the tibial Bypass group. A similarly injured
cohort of patients that did not undergo operative vascular intervention
(No Bypass group) was identified. All tibial vessel injuries were documented
by angiography. Data were compiled via medical records and patient inter-
view. The primary outcome measure was failure of limb salvage. Multivariate
regression was performed to identify factors associated with revasculariza-
tion and to describe factors associated with amputation.
Results: Between March 2003 and September 2008, 135 of 1332 patients
with battle-related vascular injuries had documented tibial vessel disruption
or occlusion. Of these, 104 were included for analysis. Twenty-one under-
went autologous vein bypass at the time of injury (Bypass group), and the
remaining 83 patients were managed without revascularization (No Bypass
group). Mean follow-up (39 vs 41 months; P = .27), age (25 vs 27 years;
P = .66), and mechanism of injury (88% vs 92% penetrating blast; P = .56)
were similar, but the No Bypass group had higher Injury Severity Scores
(ISS; 16.3 vs 11.7; P < .01). Injury characteristics, including Gustilo III clas-
sification (49% vs 43%; P = .81) and nerve injury (55% vs 53%; P = 1.0), were
similar. Subjects were more likely to receive tibial bypass with an increasing
number of tibial vessel occlusions and documented ischemia on initial exam.
However, of the 23 in the No Bypass group with initially unobtainable
Doppler signals, 17 (74%) regained pedal flow following resuscitation and
limb stabilization. Amputation rates were similar (23% vs 19%; P = .79),
but the prevalence of chronic limb pain was lower in the Bypass group
(10% vs 30%, respectively; P = .08). Cox regression analysis of amputation-
free survival demonstrated an association between mangled extremity
severity score >5 (hazard ratio [HR], 2.7; P = .01) and amputation.
Conclusions: This report provides outcomes data for wartime tibial vascular
injury, which supports a selective approach to tibial artery revasculariza-
tion. Clinical factors such as ISS and degree of ischemia guide which patients
are best suited for tibial vascular repair, while injury-specific characteristics
are associated with amputation regardless of revascularization status.Trends in vena caval interruption
Phillip S. Moore, Jeanette S. Andrews, Timothy E. Craven, Ross P. Davis,
Matthew A. Corriere, Christopher J. Godshall, Matthew S. Edwards,
Kimberley J. Hansen
Objective: This study examined the national use of vena cava filters (VCFs)
from 1998 to 2005.
Methods: Methods for complex surveys were used to examine hospital
discharge data from the Nationwide Inpatient Sample (NIS) to determine
the use of VCFs for the years 1998 to 2005. VCF placement in the absence
of deep venous thrombosis (DVT) or pulmonary embolus (PE) was categorized
as prophylactic.
Results: During the study period, the estimated rate of hospitalizations per
year with a diagnosis of DVT (odds ratio [OR], 1.025; 95% confidence interval
[CI], 1.019-1.032; P < .01) or PE (OR, 1.076; 95% CI, 1.069-1.083; P < .01)
rose significantly. The estimated weighted frequency of VCF placement
increased from 52,860 procedures in 1998 to 104,114 procedures in 2005
(0.15% and 0.27% of all discharges, respectively), representing an 80%
increase. VCF placement significantly increased during hospitalizations with
any diagnosis of DVT or PE, or both, and no DVT or PE (P < .01 for each).
Logistic regression models revealed that the rate of prophylactic VCF place-
ment increased at a significantly higher rate than VCF placement associated
with DVT or PE (157% vs 42%; P < .01), after adjusting for age, gender, and
hospital characteristics. Prophylactic VCF placement in the setting of morbid
obesity (P < .01) and head injury (P = .03) rose significantly over time.
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placement increased at a significantly higher rate than VCF placement in
the setting of DVT or PE. Significant increases in the use of prophylactic VCFs
were seen in the setting of morbid obesity and head injury.Primary balloon angioplasty plus balloon angioplasty maturation to
upgrade small-caliber veins (<3 mm) for arteriovenous fistulas
Lorena Paola De Marco Garcia, Luis R. Davila-Santini, Qin Feng, Julio
Calderin, Kambhampaty V. Krishnasastry, Thomas F. Panetta
Objective: Small-diameter veins are often a limiting factor for the success-
ful creation of arteriovenous fistulas (AVFs). This study evaluated the use of
intraoperative primary balloon angioplasty (PBA) as a technique to upgrade
small-diameter veins during AVF creation. Sequential balloon angioplasty
maturation (BAM) was evaluated as a technique to salvage failed fistulas,
expedite maturation, and improve the patency of AVFs after PBA.
Methods: Sixty-two PBAs were performed in 55 patients with an intent-to-
treat using an all-autologous policy. PBAs of veins were performed just
before AVF creation using 2.5- to 4-mm angioplasty balloons (1- to 1.5-mm
larger than the nominal vein diameter). PBAs were performed through the
spatulated end of the vein for a length of up to 8 cm using hydrophilic guide-wires and hand inflations without fluoroscopy. BAM was performed in 53 of
the 62 PBAs at 2, 4, and 6 weeks after the PBA. Successful outcome was
determined as the functional ability to use the fistula for hemodialysis
without surgical revision.
Results: Of the 62 PBAs, 53 (85.4%), comprising 47 of the original AVFs and 6
new site AVFs created at other sites, remained patent and subsequently
underwent BAM with a resulting functional AVF. Fifteen of the 47 original
AVFs: 14 due to occlusion; one AVF with a steal was ligated. Seven of the
14 fistulas that occluded were salvaged using recanalization techniques
during sequential BAMs. Two of the seven fistulas that were not salvaged
required AVGs (3%), and five patients underwent redo AVFs using alternative
veins. These five cases were also performed using PBAs and BAMs technique.
One patient with a functioning fistula underwent intentional ligation for
steal syndrome and also underwent an alternative site AVF, PBA, and BAM.
At 3 months, 53 AVFs were functional and successfully used for dialysis.
Overall, a working AVF was obtained at the initial site in 47 of 55 patients
(85.4%), and 53 (96.3%) received working AVFs that were functioning for
dialysis access.
Conclusions: Small or suboptimal veins can undergo PBA and then be
matured to create functioning AVFs 2 months. Overall, >90% autogenous
AVF rates can be achieved using PBA and BAM. BAM can be successfully used
to mature AVFs created from small veins and salvage thrombosed AVFs in
many cases. The use of these techniques may decrease the number of
patients requiring AVGs and indwelling catheters.
